Incorporated in 2019, Gujarat Kidney & Super Speciality Ltd. is a multispeciality healthcare provider operating seven hospitals and four pharmacies across Gujarat, with a total bed capacity of nearly 500 beds. The company specializes in renal sciences, urology, and super-speciality surgical procedures, supported by an experienced team of doctors and medical staff.
Gujarat Kidney IPO — Price Band, Dates, Lot Size, Financials | NSE BSE
IPO Dates
22 – 24 Dec 2025
Listing Date
30 Dec 2025 (Tentative)
Market Cap
₹898.81 Cr (Pre-IPO)
Gujarat Kidney IPO Details
| Issue Type | Book Building IPO |
|---|
| Face Value | ₹2 per share |
|---|
| Fresh Issue | 2,20,00,000 shares |
|---|
| Total Issue Size | ₹250.80 Crore |
|---|
| Listing At | BSE, NSE |
|---|
| Registrar | MUFG Intime India Pvt. Ltd. |
|---|
| Lead Manager | Nirbhay Capital Services Pvt. Ltd. |
|---|
IPO Timeline
| IPO Open Date | Mon, 22 Dec 2025 |
|---|
| IPO Close Date | Wed, 24 Dec 2025 |
|---|
| Allotment | Fri, 26 Dec 2025 |
|---|
| Refunds | Mon, 29 Dec 2025 |
|---|
| Shares Credit | Mon, 29 Dec 2025 |
|---|
| Listing Date | Tue, 30 Dec 2025 |
|---|
| UPI Cut-off | 5 PM on 24 Dec 2025 |
|---|
Gujarat Kidney IPO Lot Size
| Category | Lots | Shares | Amount (₹114) |
|---|
| Retail (Min) | 1 | 128 | ₹14,592 |
| Retail (Max) | 13 | 1,664 | ₹1,89,696 |
| S-HNI (Min) | 14 | 1,792 | ₹2,04,288 |
| B-HNI (Min) | 69 | 8,832 | ₹10,06,848 |
Company Financials (₹ Crore)
| Period | FY25 | FY24 | FY23 |
|---|
| Total Income | 40.40 | 5.48 | 0.00 |
| PAT | 9.50 | 1.71 | -0.01 |
| EBITDA | 16.55 | 1.95 | -0.01 |
| Net Worth | 25.71 | 10.80 | 0.37 |
Key Performance Indicators
| ROE | 36.61% |
|---|
| ROCE | 37.65% |
|---|
| Debt / Equity | 0.15 |
|---|
| Pre IPO P/E | 61.62x |
|---|
| Post IPO P/E | 41.59x |
|---|
About Gujarat Kidney & Super Speciality Ltd.
Incorporated in 2019, Gujarat Kidney & Super Speciality Ltd. is a multispeciality healthcare provider operating seven hospitals and four pharmacies across Gujarat, with a total bed capacity of nearly 500 beds. The company specializes in renal sciences, urology, and super-speciality surgical procedures, supported by an experienced team of doctors and medical staff.
Objects of the Issue
- Acquisition of Parekhs Hospital, Ahmedabad
- Capital expenditure for new hospital in Vadodara
- Purchase of robotics equipment
- Repayment of borrowings and inorganic growth
Refer to RHP for complete breakup of utilization.
Looking at the solid performance in FY25, with a significant jump in PAT and EBITDA, Gujarat Kidney seems well-positioned for growth. Still, it’ll be crucial to monitor how they scale their operations post-IPO to maintain profitability.